The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Author Title [ Type(Desc)] Year
Filters: Author is Polyzos, Stergios A  [Clear All Filters]
Journal Article
Makras, P., Papapoulos S. E., Polyzos S. A., Appelman-Dijkstra N. M., & Anastasilakis A. D. (2020).  The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosis.. Bone. 138, 115478.
Efstathiadou, Z. A., Kita M. D., & Polyzos S. A. (2018).  Thyroid dysfunction and non-alcoholic fatty liver disease.. Minerva Endocrinol. 43(3), 367-376.
Polyzos, S. A., Kita M., & Avramidis A. (2007).  Thyroid nodules - stepwise diagnosis and management.. Hormones (Athens). 6(2), 101-19.
Toulis, K. A., Goulis D. G., Tsolakidou K., Hilidis I., Fragkos M., Polyzos S. A., et al. (2013).  Thyrotropin receptor autoantibodies and early miscarriages in patients with Hashimoto thyroiditis: a case-control study.. Gynecol Endocrinol. 29(8), 793-6.
Polyzos, S. A., Goulas A., & Papaioannidou P. (2023).  Tirzepatide for Diabetes and Obesity: A New Window to the Treatment of Non-alcoholic Steatohepatitis.. Curr Med Chem.
Polyzos, S. A., Anastasilakis A. D., & Terpos E. (2009).  Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.. Support Care Cancer. 17(10), 1329-30.
Doulberis, M., Polyzos S. A., Papaefthymiou A., Katsinelos P., Kiosses C., & Kountouras J. (2020).  Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents.. Expert Opin Pharmacother. 21(3), 247-251.
Polyzos, S. A., & Goulas A. (2020).  Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: A hypothesis on drug repurposing.. Med Hypotheses. 110379.
Boziki, M., Grigoriadis N., Papaefthymiou A., Doulberis M., Polyzos S. A., Gavalas E., et al. (2021).  The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis.. Neurochem Int. 144, 104938.
Kountouras, J., Gavalas E., Papaefthymiou A., Tsechelidis I., Polyzos S. A., Bor S., et al. (2020).  Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.. Medicina (Kaunas). 56(7), 
Vachliotis, I. D., Valsamidis I., & Polyzos S. A. (2023).  Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.. Cancers (Basel). 15(21), 
Doulberis, M., Papaefthymiou A., Srivastava D. S., Exadaktylos A. K., Katsinelos P., Kountouras J., et al. (2020).  Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection.. Int J Clin Pract. e13737.
Polyzos, S. A., & Mantzoros C. S. (2015).  An update on the validity of irisin assays and the link between irisin and hepatic metabolism.. Metabolism. 64(9), 937-42.
Polyzos, S. A., Kountouras J., Polymerou V., Papadimitriou K. G., Zavos C., & Katsinelos P. (2016).   Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease.. Ann Hepatol. 15(5), 705-14.
Polyzos, S. A., & Kountouras J. (2012).  Visual vignette. Anaplastic thyroid carcinoma.. Endocr Pract. 18(1), 108.
Doulberis, M., Papaefthymiou A., Kountouras J., Polyzos S. A., Srivastava S., Klokowska-Röetzler J., et al. (2019).  Vitamin D Deficiency and Unclear Abdominal Pain in Patients from Low- and Middle-Income Countries.. Int J Environ Res Public Health. 16(23), 
Polyzos, S. A., Kountouras J., Anastasilakis A. D., & Terpos E. (2023).  Wnt/beta-catenin signaling inhibitors and nonalcoholic fatty liver disease: Potential therapeutic implications.. Hepatobiliary Pancreat Dis Int.
Anastasilakis, A. D., Papapoulos S. E., Polyzos S. A., Appelman-Dijkstra N. M., & Makras P. (2019).  Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.. J Bone Miner Res.
Anastasilakis, A. D., Polyzos S. A., Kitridis D., Makras P., Yavropoulou M. P., Palermo A., et al. (2021).  Ιrisin levels in postmenopausal women with an incident hip fracture.. Endocrine. 73(3), 719-722.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.